Urinary Tract Infection Therapeutics Market: Global Outlook and Competitive Dynamics 2025

Urinary Tract Infection Therapeutics Market is driven by increase in diagnosis and prevalence rate of diseases such as diabetes and kidney stone.

Urinary tract infection is one of the most common type of bladder infections. Any part of urinary tract may be infected, including ureters, kidneys, urethra, and bladder. Most infections involve the lower urinary tract, therefore different names are given for it according to part where infection occurs. Bladder infection is known as cystitis. Urethra infection is known as urethritis. Infection in kidney is called as pyelonephritis. Urinary tract infection is caused due to entry of bacteria into the urinary system. This results in swelling, pain, and redness in the urinary tract. Treatment of urinary tract infection cannot be done promptly because if bacteria reaches up to the kidney it can cause more severe infection such as pyelonephritis.

Read the Comprehensive Overview of Urinary Tract Infection Therapeutics Market: http://www.transparencymarketresearch.com/urinary-tract-infection-therapeutics-market.html

Although urinary tract infection is the second most common infection, according to National Kidney Foundation, women are more likely to have it. Few women experience it regularly, which is known as recurrent urinary tract infection. This may be due to shorter urethra in women, which might make it easier for bacteria to pass through the bladder. Moreover, one in five women suffer from urinary tract infection at some point of time. Symptoms of urinary tract infection include frequent urge to urinate and a burning and painful sensation when urinating, cloudy or blood-tinged urine, and strong odor of the urine. Causes of urinary tract infection include nausea and vomiting, sexual intercourse, diabetes, poor personal hygiene, bowel incontinence, blockages in urinary tract, such as a kidney stone, or enlarged prostate gland in a man can also block the flow of urine and cause urinary tract infection. People having urinary catheter in bladder for a long period are more likely to have urinary tract infection.

The urinary tract infection therapeutics market is set to witness strong grow due to increase in diagnosis and prevalence rate of diseases such as diabetes and kidney stone. Urinary tract infection is largely treated with antibiotics. The urinary tract infection therapeutics market has been segmented based on drug type, distribution channel, and region. In terms of drug type, the market has been categorized into quinolones, penicillin & combinations, cephalosporin, azoles & amphotericin B, sulphonamides, aminoglycoside-antibodies, nitrofurans, and tetracycline. The generic, low cost competition for few of the drugs and rising prevalence and early diagnosis of urinary tract infection is likely to boost the market in the near future.

Based on distribution channel, the urinary tract infection therapeutics market has been segmented into hospital pharmacies, retail pharmacies, and e-commerce. The retail pharmacies and hospital pharmacies segments hold the major share of the market.

In terms of region, the global urinary tract infection therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the global urinary tract infection therapeutics market due to high health care awareness, high diagnostic rate, and high prevalence of disease such as diabetes in the region. Europe accounted for the second largest share of the market due to rising research and development. However, countries in Asia are expected to be the fastest growing markets due to growing awareness, increasing personal care and hygiene, rising rate of diagnostics, gradual adoption of improved technologies, emerging health care infrastructures, and increased disposable income. Increasing geriatric population is another factor expected to boost demand for urinary tract infection therapeutics as the population is at high risk of the infection.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=27035

Major players in the urinary tract infection therapeutics market are Pfizer, Inc., AstraZeneca plc, Novartis International AG., Johnson & Johnson, F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, and Cipla Ltd., among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/


Contact Details

Company Name: Transparency Market Research
Issued By: Aman Gambhi
Phone: +1-518-618-1030
Address: 90 State Street, Suite 700 Albany, NY 12207
City: Albany
State: NY
Zip: 12207
Country: United States
Website: Visit the website

Keywords : Urinary Tract Infection Therapeutics Market,

by Aman Gambhi (few months ago!)

Latest Press Releases

Text My Main Number Announced Major Shift of US Businesses toward Landline Texting

Global Department Stores Retailing 2015-2020: Ken Research

Global M-Health Device Market : Latest Research

Global Zinc Selenide Market Professional Survey Report 2017 to its Products Forecast – RAIN G..

Diesel Fuel Injection Systems 2017 Development, Trends, Share, Growth, Research and Market An..

Global Soil Testing, Inspection, and Certification Market Size, Status – ALS Ltd, Assure Qual..

Silicon Carbide Ceramics 2017 Annual Growth Value, Market Trends, Developments & Opportunities

5.1% CAGR Anticipated for Demineralized Whey Powder Ingredient Market During 2017-2027

Acoustic Wall Panels Market Forecasts, Size, Share, Regional Outlook 2017 to 2022

Rehm goes India

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.